This week, the team discuss Vertex's acquisition of Exonics and expansion of its collaboration with CRISPR Therapeutics. Also, we take an indepth look at the European Medicines Agency's approval of Bluebirdbio's gene therapy Zynteglo as a treatment for beta-thalassemia .
Presenter: Aparna Krishnan
Contributor: Jack Rawson
Producer: Aparna Krishnan
Weekly Roundup: November 5, 2019
Weekly RoundUp: August 5, 2019
Weekly Roundup: July 29, 2019
Weekly Roundup: July 22, 2019
Weekly Roundup: July 1, 2019
Weekly Roundup: June 23, 2019
Weekly Roundup: June 16, 2019
Weekly RoundUp: June 3, 2019
Weekly Roundup: May 25, 2019
Weekly Roundup: May 18, 2019
Weekly Roundup: May 12, 2019
Weekly Roundup: May 3, 2019
Weekly Roundup: April 27, 2019
Weekly Roundup: April 22, 2019
Weekly Roundup: April 12, 2019
Weekly Roundup: March 28, 2019
Weekly Roundup: March 22, 2019
Weekly Roundup: March 15, 2019
Weekly Roundup: March 8, 2019
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain